Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Costs and benefits.
The costs of outpatient parenteral antibiotic therapy are outweighed by the benefits to all involved: provider, payer, patient, and society. Simple comparisons of inpatient and outpatient charges are not a true measure of costs. Recent in-depth cost-benefit analyses reveal a significant saving when indirect benefits, such as increased productivity and quality of life, are included. Even so, financial issues remain to be addressed.
Alexandria Hospital, VA.
G
G
Milkovich
D000553:Ambulatory Care / Q000191:economics* / Q000706:statistics & numerical data; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D004180:Direct Service Costs; D016527:Drug Costs; D004465:Economic Competition; D004526:Efficiency; D005249:Fees and Charges; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006699:Home Care Services / Q000191:economics / Q000706:statistics & numerical data; D006801:Humans; D007262:Infusions, Intravenous / Q000191:economics*; D008389:Marketing of Health Services / Q000191:economics; D011788:Quality of Life; D014481:United States
D000900:Anti-Bacterial Agents